PNC-27 - 10 MG

PNC-27 - Target: Oncology, Molecular Pathophysiology, and Experimental Therapeutics.

Core Focal Point: HDM-2 Target Profiling and Selectively Induced Membranolytic Necrosis.

1. Molecular Design & Engineering.

PNC-27 is a synthetic, chimeric 32-amino acid peptide originally designed by a supercomputer in 2000. It consists of two distinct segments fused together:

• The Warhead Segment (Residues 12–26 of p53): This portion matches the exact sequence of the human p53 tumor suppressor protein that naturally binds to HDM-2 (Human Double Minute 2, also known as MDM-2 in mice).

• The Delivery Segment (Penetratin Sequence): A highly specialized, transmembrane-penetrating leader sequence derived from Antennapedia. It anchors the peptide and forces it into the plasma membrane.

2. 🎯 The Cellular Mechanism: The "Battering Ram"

To explain PNC-27 to your class, map out this molecular sequence. It exploits a unique structural mistake that only cancer cells make:

[Normal Cell: HDM-2 trapped inside the nucleus] ──► [PNC-27 ignored; cell is completely safe]
                                    
[Cancer Cell: HDM-2 is abnormally expressed on the outer cell membrane]
                                    │
                                    ▼
                     [PNC-27 Administered to Body]
                                    │
                                    ▼
       [PNC-27's Warhead Domain Binds 1:1 with Membrane-Bound HDM-2]
                                    │
                                    ▼
      [Complexes Aggregate to Form Open Transmembrane Pores (Holes)]
                                    │
                                    ▼
    [Extracellular Fluid Rushes In ──► Osmotic Lysis & Tumoral Necrosis]

Step 1: Exploiting the Cancer Biomarker (HDM-2)

In a healthy, normal cell, the HDM-2 protein stays strictly inside the nucleus, where it acts as a regulator to degrade excess p53. However, cancer cells abnormally transport large amounts of full-length HDM-2 out to their external cell membranes. Healthy cells never do this.

Step 2: Aggregation and Pore Formation.

When introduced, PNC-27 travels through the body. It completely ignores healthy cells because they have no surface HDM-2. When it finds a cancer cell, the p53 domain binds tightly (in a 1:1 molecular ratio) to the membrane-bound HDM-2. The penetratin segment then loops into the membrane, causing these PNC-27/HDM-2 complexes to stick together in layered, ring-shaped structures.

Step 3: Death by Osmotic Lysis (Explosion)

These ring structures form a physical transmembrane pore (an open hole) straight through the cancer cell’s protective wall. Extracellular fluid rapidly floods inside the cancer cell, causing it to swell up and pop. This induces necrosis (sudden cell lysis) rather than slow apoptosis, destroying the tumor cell in minutes.

3. Diseases & Malignancies That Benefit From PNC-27.

Because almost all solid tumors and blood cancers overexpress HDM-2 on their surfaces to survive, PNC-27 behaves as a broad-spectrum anti-cancer agent across a vast array of malignancies:

1. Highly Metastatic Pancreatic Cancer

• The Disease: One of the most aggressive, chemotherapy-resistant cancers, which rapidly forms dense stroma around its cells to block traditional medication.

• The Benefit: In preclinical testing, PNC-27 successfully eradicated high-metastatic-potential pancreatic tumor cells (such as the TUC-3 line) without damaging pancreatic tissue.

2. Acute & Chronic Myelogenous Leukemia (AML / CML)

• The Disease: Blood and bone marrow cancers that severely compromise the immune system. Traditional chemo wipes out a patient's healthy bone marrow stem cells, causing dangerous white blood cell crashes.

• The Benefit: Studies show PNC-27 induces rapid necrosis in human acute myelogenous leukemia cells. Crucially, it leaves healthy hematopoetic stem cells completely alone, meaning it does not cause bone marrow suppression.

3. Solid Epithelial Tumors (Breast, Cervical, and Colon Cancer)

• The Disease: Advanced cancers that form dense, physical tumor masses.

• The Benefit: Highly effective against human breast cancer cells (MCF-7), cervical cancer, and colon cancer cells. Because it punctures the membrane physically, it functions successfully even in "p53-null" cancer lines that are entirely resistant to ordinary radiation therapy.

"Most cancer drugs are chemical poisons that try to corrupt the cell from the inside out, often killing healthy cells by accident. PNC-27 is a biological drill. It targets a protein marker that only cancer cells display on their outer walls, boring holes into their membranes and causing them to burst, while leaving normal tissue completely unharmed."

Potential Risks.

Waste Filtration Load: Because it triggers massive, rapid necrosis (cell popping) rather than slow cellular recycling, destroying a very large tumor too quickly can flood the bloodstream with cellular debris, putting a heavy filtration burden on the patient’s liver and kidneys.

Product Details

• Compound: PNC-27
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture

Research Use Only

This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.

This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.

By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.